[Qnexa: a new anti-obesity threat].
jeanyves.nau@gmail.com
Jean-Yves
JY
Nau
D019440:Anti-Obesity Agents / Q000008:administration & dosage / Q000009:adverse effects*; D000697:Central Nervous System Stimulants / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D009765:Obesity / Q000188:drug therapy*; D010645:Phentermine / Q000008:administration & dosage / Q000009:adverse effects*; D019966:Substance-Related Disorders / Q000209:etiology*
D019440:Anti-Obesity Agents; D000697:Central Nervous System Stimulants; D010645:Phentermine